Marie O’Malley, Vice President of Commercial Operations at PiSA USA, will join MassMEDIC’s Fireside Chat: Breaking Barriers — Leading Through Technology Challenges in MedTech at MEDevice Boston 2025. With nearly 30 years of experience in innovation, supply chain, and regulatory
Genmab A/S and Merus N.V. announced that they have entered into a transaction agreement pursuant to which Genmab intends to acquire all the shares of Merus, a clinical-stage biotechnology company with its late-stage breakthrough therapy asset petosemtamab, which is in
SayVo AI has unveiled the next evolution of its AI-powered sales representatives, now delivering enterprise-grade scalability and seamless integration into modern sales pipelines. Built to mirror the strengths of a client’s ideal employee, these AI reps engage leads, handle objections,
Brought to you by
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
